Opioid-Induced Constipation Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Type (Peripherally restricted-opioid receptor antagonists, Non-selective opioid antagonists, Locally acting chloride channel activators), By Formulation Type (Solids, Semi-solids, Liquids), By Administration (Oral, Parenteral), By Distribution Channel (Drugstore, Retail pharmacies, Hospital pharmacies) and Region Forecast 2020-2031

Opioid Induced Constipation Treatment Market size was valued at US$ 70.3 million in 2024 and is expected to reach US$ 110.0 million by 2031, growing at a significant CAGR of 6.6% from 2025-2031. Global market are the drugs used for its pain relieving properties in non-cancer and chronic kidney diease (ckd) drugs pain. The adverse effects associated with the opioids are decreasing gastrointestinal tracts motility, making patients strain, and making of solid discharges.

Furthermore, long-term use of opioids cause harm to the sensory system, limits the release of endogenous opioids such as endorphins. Adults are most likely to prone to opioid-induced constipation owing to less immobility, poor diet, and fluid intake. The symptoms associated with the opioid-induced constipation are included dry and hard tools, leathery feeling, painful defecation, bulged abdomen, and loss of appetite. The market growing at a significant CAGR due to rise in the aging population using opioid analgesics for chronic pains. Increase in the illicit use of medications, prolonged usage of opioids in the treatment of pain, an increase in the prevalence of cancer is anticipated to boost the global Opioid-Induced Constipation Treatment Market.

Furthermore, launching of newer drugs, growing FDA approvals, positive outcomes in clinical trials, and rise in the healthcare expenditure are expected to propel the market over the forecast period. However, lack of awareness regarding opioid induced constipation in patients, the absence of treatment innovations, a high cost of newer pharmaceuticals, adverse effects, including nausea, a risk of heart problems and strokes associated with these drugs and unfavorable reimbursement policies expected to hamper the growth of the market.

This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).